Related Experiment Video
Updated: Jun 2, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
SOD1 overexpression in vivo blocks hyperglycemia-induced specific PKC isoforms: substrate activation and consequent
Xuezheng Li1, Hongbo Weng, E Albert Reece
1Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
Objective:
Oxidative stress plays a causative role in diabetic embryopathy. We tested whether mitigating oxidative stress, using superoxide dismutase 1 (SOD1) transgenic (Tg) mice, would block hyperglycemia-induced specific protein kinase C (PKC) isoform activation and its downstream cascade.
Study Design:
Day 8.5 embryos from nondiabetic wild-type control (NC), diabetic mellitus wild-type (DM), and diabetic SOD1-Tg mice (DM-SOD1-Tg) were used for detection of phosphorylated (p-) PKCα/βII and p-PKCδ, and levels of 2 prominent PKC substrates, phosphorylated myristoylated alanine-rich protein kinase C substrate (MARCKS) and receptor for activated C kinase 1 (RACK1), and lipid peroxidation markers, 4-hydroxynonenal (4-HNE) and malondialdehyde (MDA).
Results:
Levels of p-PKCα/βII, p-PKCδ, p-MARCKS, 4-HNE, and MDA were significantly elevated in the DM group compared with those in the NC group and the DM-SOD1-Tg group. The NC and DM-SOD1-Tg groups had comparable levels of these protein and lipid peroxidation markers. RACK1 levels did not differ among the 3 groups.
Conclusion:
Mitigating oxidative stress by SOD1 overexpression blocks maternal hyperglycemia-induced activation of specific PKC isoforms and downstream cascades.
Insights
Mitigating oxidative stress by overexpressing superoxide dismutase 1 (SOD1) in transgenic mice blocked hyperglycemia-induced protein kinase C (PKC) activation and its downstream effects, preventing diabetic embryopathy.
Area of Science:
- Reproductive Biology
- Developmental Biology
- Biochemistry
Background:
- Oxidative stress is a key factor in diabetic embryopathy.
- Hyperglycemia during pregnancy can lead to birth defects.
- Protein Kinase C (PKC) signaling pathways are implicated in developmental abnormalities.
Purpose of the Study:
- To investigate if mitigating oxidative stress can prevent hyperglycemia-induced PKC activation.
- To determine the role of superoxide dismutase 1 (SOD1) in protecting against diabetic embryopathy.
- To examine the downstream effects of PKC activation in diabetic embryos.
Main Methods:
- Comparison of embryos from nondiabetic control, diabetic wild-type, and diabetic SOD1-transgenic mice.
- Measurement of phosphorylated PKC isoforms (PKCα/βII, PKCδ) and their substrates (MARCKS, RACK1).
- Assessment of lipid peroxidation markers (4-HNE, MDA) to quantify oxidative stress.
Main Results:
- Diabetic embryos showed elevated levels of phosphorylated PKC isoforms and lipid peroxidation markers.
- SOD1 overexpression in diabetic embryos normalized these markers to levels comparable to non-diabetic controls.
- Levels of RACK1 did not differ significantly among the groups.
Conclusions:
- Overexpression of SOD1 effectively mitigates oxidative stress in the context of maternal diabetes.
- Reducing oxidative stress blocks hyperglycemia-induced activation of specific PKC isoforms and their downstream signaling.
- This suggests a potential therapeutic strategy for preventing diabetic embryopathy.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Diabetic Ketoacidosis ll: Pathophysiology
Type II Diabetes II: Pathophysiology
Cell Specific Gene Expression
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
